# Safety and Preliminary Efficacy Study of NeoFuse in Subjects Requiring Lumbar Interbody Fusion

> **NCT00996073** · PHASE2 · COMPLETED · sponsor: **Mesoblast, Ltd.** · enrollment: 24 (actual)

## Conditions studied

- Degenerative Disc Disease
- Degenerative Spondylolisthesis
- Spinal Stenosis

## Interventions

- **BIOLOGICAL:** Lumbar Interbody Fusion with Autograft
- **BIOLOGICAL:** Lumbar Interbody Fusion with NeoFuse
- **BIOLOGICAL:** Lumbar Interbody Fusion with NeoFuse

## Key facts

- **NCT ID:** NCT00996073
- **Lead sponsor:** Mesoblast, Ltd.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2009-09
- **Primary completion:** 2012-07
- **Final completion:** 2014-07
- **Target enrollment:** 24 (ACTUAL)
- **Last updated:** 2020-06-29


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00996073

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00996073, "Safety and Preliminary Efficacy Study of NeoFuse in Subjects Requiring Lumbar Interbody Fusion". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT00996073. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*